RxDoctor Payments Data

Eli Hammer, MD

Family Medicine · Greensboro, NCNPI 1730641556

Payments from drug & device makers

$1,805in general payments, 2019–2025

Across 105 payments — averaging $17.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$328
  • AbbVie$275
  • GSK$207
  • Lilly USA, LLC$202
  • Pfizer$112
  • Paratek Pharmaceuticals, Inc.$94
  • plus $588 from 14 others

What the payments were for

  • Food & beverage$1,805100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,805 in reported general payments places this provider in the 75th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$80,830
Medicare patients
159
Services billed
2,571

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide59$68,727
JardianceEmpagliflozin66$59,727
MounjaroTirzepatide28$46,388
FarxigaDapagliflozin Propanediol54$41,954
EliquisApixaban26$19,822
XareltoRivaroxaban18$16,183
ShingrixVaricella-Zoster Ge/As01b/Pf66$14,718
Breztri AerosphereBudesonide/Glycopyr/Formoterol16$12,721
Stiolto RespimatTiotropium Br/Olodaterol Hcl24$11,201
LinzessLinaclotide11$10,125
Breo ElliptaFluticasone/Vilanterol23$9,930
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$9,858
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr16$7,517
Boostrix TdapDiphth,pertuss(Acell),tet Vac100$7,010
Levothyroxine Sodium268$4,363

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Stiolto Respimat$92$70,92890 claims
Novo NordiskOzempic$328$68,72759 claims
AstraZenecaFarxiga, Breztri Aerosphere$64$54,67670 claims
Lilly USA, LLCMounjaro$202$46,38828 claims
GSKShingrix, Breo Ellipta, Trelegy Ellipta, Anoro Ellipta$207$42,023118 claims
PfizerEliquis$112$19,82226 claims
AbbVieLinzess, Synthroid$275$12,35134 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Greensboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →